Recombinant nuoA is typically expressed in E. coli systems for research applications. Technical specifications from commercial and academic sources include:
Salmonella strains lacking ubiquinone (a quinone substrate) exhibit compensatory upregulation of NDH-1, including nuoA, to maintain electron flux via alternative quinones (e.g., menaquinone) .
Mutations in adjacent subunits (e.g., nuoG, nuoM, nuoN) alter enzyme activity and quinone affinity, indirectly affecting nuoA’s functional context .
Data from S. enterica membrane assays highlight NDH-1 activity dependencies:
Antibiotic Resistance Studies: S. Newport ST45 strains (livestock-associated) exhibit multi-drug resistance (MDR) linked to respiratory adaptations, where NDH-1 activity may influence survival under stress .
Diagnostic Tools: Recombinant nuoA is used in ELISA kits for serotype-specific antibody detection .
Structural Biology: Supports studies on proton translocation mechanisms and quinone-binding interactions in Complex I .
KEGG: see:SNSL254_A2512
NADH-quinone oxidoreductase (also known as NDH-1 or Complex I) functions as a critical enzyme in the respiratory chain of Salmonella species. The enzyme catalyzes the transfer of electrons from NADH to quinones in the bacterial membrane, contributing to energy production through the generation of proton motive force. The nuoA subunit is one of multiple subunits that form the NDH-1 complex and is specifically located in the membrane domain of the enzyme. In Salmonella Newport, as in other Salmonella species, nuoA contributes to the structure and stability of NDH-1, which is essential for both aerobic and anaerobic respiration .
In Salmonella, ubiquinone serves as the primary mobile electron-carrier during aerobic respiration, while demethylmenaquinone and menaquinone function as alternative electron carriers during anaerobic respiration . The NADH-quinone oxidoreductase (NDH-1) transfers electrons from NADH to these quinones through a complex mechanism involving both hydrophilic and hydrophobic membrane-embedded domains. The hydrophilic domain oxidizes NADH and transfers electrons through a series of iron-sulfur clusters to the hydrophobic domain, which then reduces quinones in the membrane. This electron transfer is coupled to proton translocation across the membrane, contributing to the proton motive force necessary for ATP synthesis and other cellular processes .
While specific protocols for S. Newport nuoA expression are not directly detailed in the literature, researchers generally employ a systematic approach that can be adapted for this specific protein. The process typically involves:
Gene cloning: The nuoA gene is amplified from S. Newport genomic DNA and cloned into an expression vector containing appropriate promoter elements and affinity tags (typically His-tag).
Expression system selection: E. coli BL21(DE3) or similar strains are commonly used, with expression conditions optimized for membrane proteins (lower temperatures, specialized media).
Membrane fraction isolation: After cell disruption, the membrane fraction containing the expressed nuoA is separated by ultracentrifugation.
Solubilization: Membrane proteins require detergent solubilization (typically using n-dodecyl-β-D-maltoside or similar detergents compatible with protein function).
Purification: Affinity chromatography (Ni-NTA for His-tagged constructs) followed by size exclusion chromatography for higher purity.
Validation: SDS-PAGE, western blotting, and mass spectrometry to confirm identity and purity.
Researchers must carefully optimize detergent concentrations to maintain protein stability while effectively solubilizing the membrane fraction.
Genetic characterization of S. Newport nuoA typically involves DNA sequencing to determine its nucleotide sequence and phylogenetic analysis to compare it with nuoA genes from other Salmonella serotypes. The nuoA gene in Salmonella is part of the nuo operon, which encodes all subunits of the NADH-quinone oxidoreductase complex.
Structural characterization requires more advanced techniques:
X-ray crystallography or cryo-electron microscopy to determine the three-dimensional structure of nuoA, either in isolation or as part of the NDH-1 complex.
Circular dichroism spectroscopy to analyze secondary structure composition.
Nuclear magnetic resonance (NMR) for analyzing dynamic properties of specific domains.
Computational modeling based on homologous proteins when experimental structures are unavailable.
These approaches help determine the transmembrane topology, interaction interfaces with other subunits, and functional domains of the nuoA protein.
Detection of Salmonella Newport, including strains expressing nuoA, can be performed using several methodologies. The XP-Design Assay Salmonella Newport is a ready-to-use primer and probe solution specifically designed for the qualitative detection of DNA sequences unique to Salmonella Newport in isolated colonies or in food and environmental samples . This assay utilizes real-time PCR methodology with FAM fluorophore detection.
The standard protocol involves:
Sample enrichment following established protocols for food and environmental samples
DNA extraction using methods such as the Easy protocol of the iQ-Check Salmonella spp. II method
PCR amplification using Salmonella Newport-specific primers
The assay has been tested on various sample types including chicken carcass rinses, turkey sponge swabs, poultry boot swabs, and beef steak, demonstrating the versatility required for comprehensive food safety testing programs .
Research on nuo genes in Salmonella has revealed that mutations in these genes can significantly impact respiratory function. While specific nuoA mutations in S. Newport have not been extensively characterized, studies on other nuo genes provide valuable insights. Mutations in nuoG, nuoM, and nuoN have been shown to act as suppressors in strains with defects in ubiquinone biosynthesis, partially rescuing growth and motility .
The nuoG(Q297K), nuoM(A254S), and nuoN(A444E) mutations improved electron flow activity of NADH-quinone oxidoreductase-1 under certain growth conditions, particularly in cells unable to synthesize ubiquinone . These findings suggest that:
Mutations in nuo genes, including potentially nuoA, can alter the enzyme's ability to utilize alternative electron carriers like demethylmenaquinone or menaquinone.
Such mutations can compensate for deficiencies in the quinone pool by improving the efficiency of electron transfer through NDH-1.
The adaptation of respiratory complexes through mutation provides a mechanism for metabolic flexibility in response to changes in electron carrier availability.
These observations indicate that nuoA mutations could similarly affect S. Newport's respiratory capability and metabolic adaptability.
While direct evidence linking nuoA function to antimicrobial resistance in S. Newport is limited, several theoretical connections exist. Multidrug-resistant S. Newport strains, particularly Newport-MDRAmpC isolates, show resistance to multiple antimicrobials including extended-spectrum cephalosporins . These strains have been identified in both human and animal isolates, suggesting transmission through the food chain .
The potential relationships between nuoA and antimicrobial resistance include:
Energy-dependent resistance mechanisms: Many resistance mechanisms, including efflux pumps, require energy from the respiratory chain. Changes in nuoA function could affect energy availability for these processes.
Metabolic adaptations: Alterations in respiratory function due to nuoA mutations might trigger compensatory metabolic changes that influence susceptibility to certain antibiotics.
Growth rate effects: Respiratory efficiency impacts bacterial growth rates, which can alter susceptibility to growth-dependent antibiotics.
Interestingly, case patients with Newport-MDRAmpC infection were more likely to have taken antimicrobial agents to which these strains are resistant during the 28 days before illness onset (OR, 5.0 [95% CI, 1.6-16]) , suggesting that antibiotic use may select for resistant strains.
Salmonella's ability to utilize different quinones as electron carriers contributes significantly to its metabolic flexibility. Wild-type Salmonella cells produce ubiquinone and menaquinone, while strains with disrupted ubiquinone biosynthesis produce alternative quinones like demethylmenaquinone . This flexibility in quinone utilization allows Salmonella to adapt to various environmental conditions.
The interaction between nuoA and different quinones likely influences:
Respiratory efficiency under aerobic vs. anaerobic conditions
Energy yield from different carbon sources
Ability to colonize different niches within hosts
Survival under environmental stress conditions
Experimental evidence shows that NDH-1 can transfer electrons to demethylmenaquinone or menaquinone when ubiquinone is unavailable , demonstrating the respiratory complex's adaptability. The nuoA subunit, as part of the membrane domain of NDH-1, likely contributes to these quinone interactions, though specific mechanisms require further investigation.
While direct evidence for nuoA's role in chemotaxis is limited, research on respiratory function and motility provides valuable insights. Ubiquinone biosynthesis mutants show poor swimming abilities in soft tryptone agar, indicating that proper respiratory function is essential for motility . Suppressor mutations in nuo genes partially rescue this motility defect, suggesting that NADH-quinone oxidoreductase function directly impacts swimming ability.
Recent research has shown that S. Newport exhibits chemotactic attraction to fecal treatments, with even "tighter accumulation of cells at the treatment source compared to S. Typhimurium IR715" . This chemotactic behavior requires energy provided by the respiratory chain, in which nuoA participates as part of NDH-1.
The connections between nuoA and motility likely involve:
Energy provision for flagellar rotation through the proton motive force
Metabolic sensing that influences chemotactic responses
Adaptation to different electron acceptors during chemotaxis through varying environments
These relationships highlight how respiratory components like nuoA contribute to the complex behaviors that facilitate Salmonella's survival and pathogenesis.
Structural analysis of nuoA can provide significant insights into evolutionary adaptations of Salmonella Newport. By comparing nuoA structures across different Salmonella serotypes and related bacteria, researchers can identify:
Conserved domains that indicate essential functional regions maintained through evolutionary pressure
Variable regions that might reflect adaptation to specific hosts or environments
Structural features that influence interaction with serotype-specific quinone profiles
Co-evolutionary patterns with other respiratory components
Such analyses could help explain why certain Salmonella serovars like Newport have emerged as significant human pathogens while maintaining animal reservoirs. The prevalence of Salmonella Newport in both humans and food animals, particularly cattle (93% of cattle isolates in one study were Newport-MDRAmpC) , suggests specific adaptations that facilitate cross-species transmission.
Based on established methodologies, several assays can be employed to measure NADH-quinone oxidoreductase (NDH-1) activity in Salmonella Newport:
| Assay Type | Principle | Components Measured | Advantages | Limitations |
|---|---|---|---|---|
| dNADH-oxidase | Measures NADH oxidation rate with endogenous quinones | Complete NDH-1 electron transfer chain | Reflects physiological activity | Dependent on endogenous quinone pool |
| dNADH-DB | Uses exogenous ubiquinone analogue (DB) | NDH-1 electron transfer independent of quinone pool | Controls for quinone variations | May not reflect in vivo conditions |
| dNADH-K₃Fe(CN)₆ reductase | Measures NADH dehydrogenase domain activity | Hydrophilic domain function only | Isolates specific domain function | Doesn't measure complete electron transfer |
The protocols typically involve:
Preparation of membrane fractions from bacterial cultures
Spectrophotometric measurement of reaction rates under controlled conditions
Use of specific inhibitors (e.g., capsaicin-40) to confirm specificity and determine IC₅₀ values
Data analysis to determine activity rates and enzyme kinetics
For accurate assessment, researchers should control for protein concentration and use appropriate negative controls such as Δnuo mutant strains .
Generation and characterization of nuoA mutants requires a systematic approach:
Mutagenesis Strategies:
Targeted mutagenesis:
CRISPR-Cas9 system for precise genomic editing
Lambda Red recombination for gene replacement
Site-directed mutagenesis for specific amino acid changes
Random mutagenesis:
Error-prone PCR to generate libraries of mutations
Chemical mutagens followed by selection for phenotypes of interest
Transposon mutagenesis with subsequent identification of nuoA insertions
Characterization Methods:
Genetic verification:
Whole-genome sequencing to confirm mutations and identify potential secondary mutations
PCR amplification and sequencing of the nuoA region
Southern blotting to verify genomic integration
Functional analysis:
Growth curves under aerobic and anaerobic conditions
Motility assays in soft agar
Respiratory enzyme assays (as detailed in section 3.1)
Quinone pool analysis by HPLC
Protein expression analysis by immunoblotting
Phenotypic assessment:
Antimicrobial susceptibility testing
Biofilm formation assays
Virulence in animal models
Competitive fitness assays
This comprehensive approach allows researchers to understand the specific contributions of nuoA to Salmonella Newport physiology and pathogenesis.
Studying in vivo expression of nuoA during infection requires techniques that can detect gene expression in the context of host tissues:
Transcriptional reporters:
Construction of nuoA-reporter fusions (luciferase, GFP)
Integration of reporters into the chromosome to maintain native regulation
In vivo imaging in animal models to track expression patterns
RNA analysis:
RNA extraction from infected tissues followed by qRT-PCR
RNA-seq to measure nuoA expression relative to the entire transcriptome
In situ hybridization to localize nuoA expression within host tissues
Protein detection:
Generation of specific antibodies against nuoA for immunohistochemistry
Tagged versions of nuoA (e.g., His-tag) for detection in recovered bacteria
Proteomics analysis of bacteria recovered from infected tissues
Single-cell approaches:
Laser capture microdissection to isolate bacteria from specific host niches
Single-cell RNA-seq to assess nuoA expression in individual bacteria
Flow cytometry sorting of bacteria expressing fluorescent reporters
Environmental parameter measurement:
Correlation of nuoA expression with oxygen levels in different host tissues
Analysis of nutrient availability and its impact on nuoA expression
pH measurement to correlate with expression patterns
These methods can reveal how nuoA expression changes throughout the infection process and in different host compartments, providing insights into its role in pathogenesis.
Distinguishing primary effects of nuoA mutations from compensatory changes requires a multi-faceted approach:
| Approach | Methodology | Outcome Measured | Advantages | Limitations |
|---|---|---|---|---|
| Complementation analysis | Introduction of wild-type nuoA on plasmid | Phenotype restoration | Directly tests nuoA function | Plasmid copy number effects |
| Temporal gene expression | RNA-seq at different timepoints after mutation | Sequential adaptation | Captures adaptation dynamics | Complex data interpretation |
| Targeted proteomics | Quantification of specific respiratory proteins | Compensatory protein changes | Focused on relevant pathways | May miss unexpected adaptations |
| Suppressor mutation analysis | Identification of secondary mutations | Genetic compensation | Identifies genetic interactions | Labor intensive |
| Metabolic flux analysis | Isotope labeling and metabolite tracking | Pathway adaptations | Measures actual metabolic changes | Technical complexity |
Additional approaches include:
Controlled mutation introduction:
Inducible expression systems to control timing of nuoA mutation
Temperature-sensitive alleles for conditional phenotypes
Sequential introduction of mutations to track adaptation
Comparative omics:
Parallel analysis of transcriptome, proteome, and metabolome
Integration of datasets to identify coordinated responses
Network analysis to identify regulatory nodes
Evolutionary approaches:
Experimental evolution to track adaptation to nuoA mutations
Comparison of independently evolved lines
Reversion analysis to identify essential compensatory changes
Through these approaches, researchers can build a comprehensive understanding of how nuoA mutations directly affect bacterial physiology and what compensatory mechanisms emerge to maintain cellular function.
Assessment of nuoA-quinone interactions requires specialized techniques addressing both biochemical interactions and functional consequences:
Biochemical interaction analysis:
Isothermal titration calorimetry to measure binding affinities
Surface plasmon resonance for real-time binding kinetics
Fluorescence quenching assays with labeled quinones
Cross-linking followed by mass spectrometry to identify interaction sites
Functional assessments:
Enzyme kinetics with different quinone substrates
Inhibitor studies using quinone analogues
Site-directed mutagenesis of predicted quinone-binding residues
Reconstitution of purified components in liposomes
Structural approaches:
Cryo-EM of NDH-1 with bound quinones
Molecular dynamics simulations of quinone binding
Hydrogen-deuterium exchange mass spectrometry to identify conformational changes
NMR analysis of specific domains with isotope-labeled quinones
In vivo approaches:
Growth studies with quinone biosynthesis mutants
Complementation with exogenous quinones
Competition assays under conditions favoring different quinones
Respiration measurements with membrane vesicles
These techniques can reveal how nuoA contributes to quinone specificity and how different quinones influence NDH-1 function in Salmonella Newport.
The essential role of respiratory function in bacterial survival makes nuoA a potential target for novel antimicrobial strategies against multidrug-resistant Salmonella Newport:
| Strategy | Mechanism | Advantages | Challenges | Current Research Status |
|---|---|---|---|---|
| Small molecule inhibitors | Direct binding to nuoA | High specificity | Membrane permeability | Early-stage research |
| Quinone analogues | Competition with natural quinones | Leverages existing transport | Potential off-target effects | Proof-of-concept studies |
| Peptide inhibitors | Disruption of protein-protein interactions | Highly specific targeting | Delivery into bacterial cells | Theoretical |
| Combination therapy | Respiratory inhibition + conventional antibiotics | Reduced resistance development | Complex pharmacodynamics | Preclinical research |
| Immunological targeting | Antibody-mediated during infection | Host immune enhancement | Limited accessibility | Theoretical |
The fact that Newport-MDRAmpC isolates show resistance to at least nine antimicrobials highlights the urgent need for novel therapeutic approaches. Targeting respiratory components like nuoA represents a strategy distinct from conventional antibiotic targets, potentially overcoming existing resistance mechanisms.
Additionally, nuoA-targeting compounds could be particularly effective against Salmonella Newport in specific environments where the bacterium relies heavily on nuoA function, such as in the anaerobic environment of the intestine or within host cells.
The nuoA gene and its protein product offer several opportunities for improving Salmonella Newport detection:
Molecular detection:
Immunological approaches:
Production of antibodies against exposed epitopes of nuoA
Development of lateral flow assays for rapid detection
ELISA-based methods for quantitative analysis
Functional detection:
Assays measuring NDH-1 activity profiles characteristic of S. Newport
Metabolic fingerprinting based on respiratory patterns
Growth-based methods in selective media targeting respiratory capabilities
Biosensor development:
Whole-cell biosensors responding to S. Newport-specific nuoA
Aptamer-based detection of nuoA or its functional products
Electronic sensors coupled with specific recognition elements
These approaches could enhance the specificity and sensitivity of Salmonella Newport detection, particularly in complex food matrices and environmental samples where current methods face challenges.
Comparative analysis of NADH-quinone oxidoreductase across foodborne pathogens reveals important similarities and differences:
Understanding these differences can provide insights into the unique aspects of Salmonella Newport's physiology and pathogenesis, potentially revealing vulnerabilities that can be exploited for control strategies.
Research on nuoA and respiratory function has significant implications for understanding Salmonella Newport transmission through the food chain:
Survival in food environments: Respiratory flexibility contributed by nuoA and other NDH-1 components may enhance S. Newport's ability to persist in various food products. This is supported by evidence that Newport-MDRAmpC isolates are found in multiple food animals, including 93% of cattle isolates, 70% of swine isolates, and 30% of chicken isolates in one study .
Adaptation to food processing conditions: nuoA function may contribute to S. Newport's ability to adapt to stresses encountered during food processing, such as temperature fluctuations, pH changes, and exposure to sanitizers.
Host-to-host transmission: The ability to utilize different electron acceptors through NDH-1 likely contributes to S. Newport's successful transmission between different host species. Case-control studies have found that consumption of uncooked ground beef (OR, 7.8 [95% CI, 1.4-44]) and runny scrambled eggs or omelets (OR, 4.9 [95% CI, 1.3-19]) are risk factors for Newport-MDRAmpC infection .
Environmental persistence: Respiratory adaptability may facilitate survival in environmental reservoirs between hosts, contributing to the pathogen's epidemiological success.
These insights could inform risk assessment models and intervention strategies targeting specific points in the food chain where S. Newport's respiratory adaptability plays a crucial role in transmission.
Several key research directions would significantly advance understanding of nuoA in Salmonella Newport:
Structural biology:
High-resolution structures of nuoA within the complete NDH-1 complex
Structural changes associated with different quinone interactions
Conformational dynamics during electron transfer
Systems biology:
Integration of transcriptomics, proteomics, and metabolomics data
Network analysis of respiratory adaptations in different environments
Mathematical modeling of respiratory chain function and adaptation
Host-pathogen interactions:
Role of nuoA in colonization of different host tissues
Impact of host-derived factors on nuoA function
Contribution to survival within host cells
Evolutionary studies:
Comparative genomics across Salmonella serotypes
Experimental evolution under different selective pressures
Tracking of nuoA mutations in clinical and environmental isolates
Translational research:
Development of nuoA-targeted antimicrobials
Exploitation of nuoA function for improved detection methods
Vaccine strategies incorporating respiratory antigens
These research directions would not only advance fundamental understanding of Salmonella Newport biology but also contribute to applied aspects of detection, control, and treatment of this important foodborne pathogen.